Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up
- PMID: 15039412
- DOI: 10.1001/jama.291.12.1456
Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up
Abstract
Context: Because menorrhagia is often a reason for seeking medical attention, it is important to consider outcomes and costs associated with alternative treatment modalities. Both the levonorgestrel-releasing intrauterine system (LNG-IUS) and hysterectomy have proven effective for treatment of menorrhagia but there are no long-term comparative studies measuring cost and quality of life.
Objective: To compare outcomes, quality-of-life issues, and costs of the LNG-IUS vs hysterectomy in the treatment of menorrhagia.
Design, setting, and participants: Randomized controlled trial conducted between October 1, 1994, and October 6, 2002, and enrolling 236 women (mean [SD] age, 43 [3.4] years) referred to 5 university hospitals in Finland for complaints of menorrhagia.
Interventions: Participants were randomly assigned to treatment with the LNG-IUS (n = 119) or hysterectomy (n = 117) and were monitored for 5 years.
Main outcome measures: Health-related quality of life (HRQL) as measured by the 5-Dimensional EuroQol and the RAND 36-Item Short-Form Health Survey, other measures of psychosocial well-being (anxiety, depression, and sexual function), and costs.
Results: After 5 years of follow-up, 232 women (99%) were analyzed for the primary outcomes. The 2 groups did not differ substantially in terms of HRQL or psychosocial well-being. Although 50 (42%) of the women assigned to the LNG-IUS group eventually underwent hysterectomy, the discounted direct and indirect costs in the LNG-IUS group (2817 dollars [95% confidence interval, 2222 dollars-3530 dollars] per participant) remained substantially lower than in the hysterectomy group (4660 dollars [95% confidence interval, 4014 dollars-5180 dollars]). Satisfaction with treatment was similar in both groups.
Conclusions: By providing improvement in HRQL at relatively low cost, the LNG-IUS may offer a wider availability of choices for the patient and may decrease costs due to interventions involving surgery.
Comment in
-
Evaluating gynecological surgical procedures: trials and tribulations.JAMA. 2004 Mar 24;291(12):1503-4. doi: 10.1001/jama.291.12.1503. JAMA. 2004. PMID: 15039418 No abstract available.
Similar articles
-
Quality of life and costs of levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of menorrhagia: a 10-year randomized controlled trial.Am J Obstet Gynecol. 2013 Dec;209(6):535.e1-535.e14. doi: 10.1016/j.ajog.2013.08.041. Epub 2013 Aug 30. Am J Obstet Gynecol. 2013. PMID: 23999423 Clinical Trial.
-
The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower abdominal pain and back pain among women treated for menorrhagia: a five-year randomized controlled trial.Acta Obstet Gynecol Scand. 2009;88(12):1389-96. doi: 10.3109/00016340903297150. Acta Obstet Gynecol Scand. 2009. PMID: 19878089 Clinical Trial.
-
Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial.Lancet. 2001 Jan 27;357(9252):273-7. doi: 10.1016/S0140-6736(00)03615-1. Lancet. 2001. PMID: 11214131 Clinical Trial.
-
Progestogen-releasing intrauterine systems for heavy menstrual bleeding.Cochrane Database Syst Rev. 2020 Jun 12;6(6):CD002126. doi: 10.1002/14651858.CD002126.pub4. Cochrane Database Syst Rev. 2020. PMID: 32529637 Free PMC article.
-
The levonorgestrel-releasing intrauterine system as an alternative to hysterectomy in peri-menopausal women.Contraception. 2007 Jun;75(6 Suppl):S152-4. doi: 10.1016/j.contraception.2007.01.003. Epub 2007 Feb 23. Contraception. 2007. PMID: 17531608 Review.
Cited by
-
Hysterectomy for Benign Uterine Disease.Dtsch Arztebl Int. 2016 Apr 8;113(14):242-9. doi: 10.3238/arztebl.2016.0242. Dtsch Arztebl Int. 2016. PMID: 27146592 Free PMC article. Review.
-
Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations.Pharmacoecon Open. 2017 Jun;1(2):79-97. doi: 10.1007/s41669-017-0015-6. Pharmacoecon Open. 2017. PMID: 29442336 Free PMC article. Review.
-
Cost-effectiveness Analysis of Genotype-Specific Surveillance and Preventive Strategies for Gynecologic Cancers Among Women With Lynch Syndrome.JAMA Netw Open. 2021 Sep 1;4(9):e2123616. doi: 10.1001/jamanetworkopen.2021.23616. JAMA Netw Open. 2021. PMID: 34499134 Free PMC article.
-
Abnormal uterine bleeding: a review of patient-based outcome measures.Fertil Steril. 2009 Jul;92(1):205-16. doi: 10.1016/j.fertnstert.2008.04.023. Epub 2008 Jul 16. Fertil Steril. 2009. PMID: 18635169 Free PMC article.
-
Assessing responsiveness of generic and specific health related quality of life measures in heart failure.Health Qual Life Outcomes. 2006 Nov 24;4:89. doi: 10.1186/1477-7525-4-89. Health Qual Life Outcomes. 2006. PMID: 17125512 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical